Pfizer Acquires Metsera, Novo Nordisk Withdraws

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded11 Nov 2025

Publisherfeeds.acast.com ↗

Handlerec:2197400

Show notes

Pfizer Acquires Metsera, Novo Nordisk Withdraws from Bidding War: A Strategic Move for Novo Nordisk and a Secure Option for MetseraPfizer successfully acquired Metsera, causing a mixed reaction in the stock market. Metseras shares declined, while Novo Nordisks stock price rallied after withdrawing from the bidding war. Novo Nordisks decision was seen as a strategic move to maintain their strong cash position and focus on their existing pipeline. Metsera chose the Pfizer deal due to antitrust concerns and potential risks from the proposed Novo Nordisk structure. Meanwhile, Novo Nordisk faces increased competition in the anti-obesity drug market, with Ozempics prices decreasing in Europe.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.